Cargando…
CD317 Promotes the survival of cancer cells through apoptosis-inducing factor
BACKGROUND: Low nutrient environment is a major obstacle to solid tumor growth. However, many tumors have developed adaptive mechanisms to circumvent the requirement for exogenous growth factors. METHODS: Here we used siRNA interference or plasmid transfection techniques to knockdown or enhance CD31...
Autores principales: | Li, Xin, Zhang, Guizhong, Chen, Qian, Lin, Yingxue, Li, Junxin, Ruan, Qingguo, Chen, Youhai, Yu, Guang, Wan, Xiaochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957287/ https://www.ncbi.nlm.nih.gov/pubmed/27444183 http://dx.doi.org/10.1186/s13046-016-0391-2 |
Ejemplares similares
-
DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis
por: Li, Junxin, et al.
Publicado: (2017) -
CD317 maintains proteostasis and cell survival in response to proteasome inhibitors by targeting calnexin for RACK1-mediated autophagic degradation
por: Cheng, Jian, et al.
Publicado: (2023) -
Negative Immune Regulator TIPE2 Promotes M2 Macrophage Differentiation through the Activation of PI3K-AKT Signaling Pathway
por: Liu, Ruiling, et al.
Publicado: (2017) -
Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor
por: Yan, Dehong, et al.
Publicado: (2019) -
Targeted Therapy for HM1.24 (CD317) on Multiple Myeloma Cells
por: Harada, Takeshi, et al.
Publicado: (2014)